CN106581552A - Agent for treating coronary heart disease and preparation method of agent - Google Patents

Agent for treating coronary heart disease and preparation method of agent Download PDF

Info

Publication number
CN106581552A
CN106581552A CN201510683211.4A CN201510683211A CN106581552A CN 106581552 A CN106581552 A CN 106581552A CN 201510683211 A CN201510683211 A CN 201510683211A CN 106581552 A CN106581552 A CN 106581552A
Authority
CN
China
Prior art keywords
parts
heart disease
coronary heart
disease treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510683211.4A
Other languages
Chinese (zh)
Inventor
潘金成
王娅玲
邓文
东伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LONGLI PHARMACEUTICAL FACTORY OF GUIZHOU RUIHE PHARMACEUTICAL Co
Original Assignee
LONGLI PHARMACEUTICAL FACTORY OF GUIZHOU RUIHE PHARMACEUTICAL Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LONGLI PHARMACEUTICAL FACTORY OF GUIZHOU RUIHE PHARMACEUTICAL Co filed Critical LONGLI PHARMACEUTICAL FACTORY OF GUIZHOU RUIHE PHARMACEUTICAL Co
Priority to CN201510683211.4A priority Critical patent/CN106581552A/en
Publication of CN106581552A publication Critical patent/CN106581552A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an agent for treating coronary heart disease and a preparation method of the agent. The agent is prepared from the following raw materials in parts by weight: 15-30 parts of radix angelicae sinensis, 30-55 parts of radix rehmanniae praeparata, 20-35 parts of herba cistanche, 10-55 parts of unprocessed rehmannia root, 10-20 parts of ginseng, 10-30 parts of radix ophiopogonis, 3-12 parts of fruit of Chinese magnoliavine, 7-15 parts of liquorice root, 10-40 parts of radix astragali, 20-30 parts of radix scrophulariae, 20-55 parts of radix salviae miltiorrhizae, 2-15 parts of fructus amomi, 2-15 parts of rhizoma ligustici wallichii and 10-20 parts of honeysuckle flowers. The agent provided by the invention has the characteristics of being gentle in drug property and free from side effects.

Description

A kind of coronary heart disease treatment medicament and preparation method
Technical field
The present invention relates to a kind of medicament and preparation method for treating heart disease, particularly a kind of hat Worry healing potion and preparation method.
Background technology
Coronary heart disease, refers to that blood vessel-coronary artery generation of supply cardiotrophin material is serious athero- Hardening or spasm, close coronary artery stenosis or blocking, and the tube chamber that thrombosis is caused Plug, causes a kind of heart disease of myocardial ischemia-anoxemia or infraction, also known as ischemic heart disease. Coronary heart disease is the most common type that atherosclerotic causes organ lesion, is harm person in middle and old age The common disease of people's health, and rejuvenation tendency is presented.The reason for coronary artery narrows be:In blood The long-term too high, cholesterol of blood fat be deposited in accumulating over a long period on the inner membrance of coronary artery tube chamber, Ground pattern patch is formed, make that the inner membrance of otherwise smooth becomes is coarse, and soft tube wall becomes deadlock Firmly, on this basis, the blood platelet of rupture also condenses adhesion and gets on, and makes coronary lumen narrow, Even entirely shut.Coronary artery smooth entirely shuts, and causes myocardial blood supply bad, cardiac muscle Cannot get blood nutrition and necrosis be referred to as myocardial infarction, this is the performance of coronary heart disease most serious. Modern medicine is broadly divided into two classes under the guidance of this theory to cardiopathic treatment means: One is to use medicine to include expansion of blood vessels class medicine and the molten lipid drug of thrombolysis;Two it is support, takes Bridge is performed the operation.In the treatment of coronary heart disease, intervention operation and bypass surgery belong to invasive treatment, Simultaneously postoperative complication has a strong impact on the healthy of patient.Moreover above-mentioned operation The precipitation again that the rubbish such as vascular lipids can not be solved from source forms new patch, causes Make blood vessel restenosis, blocking, the problem of the not smooth old disease recurrence of myocardial blood supply.
The content of the invention
The purpose of the present invention, is to provide a kind of coronary heart disease treatment medicament and preparation method.The present invention With the property of medicine it is gentle, have no side effect the characteristics of.
What the present invention was realized in.A kind of coronary heart disease treatment medicament, it is matched somebody with somebody with following weight The raw material of ratio is made,
More preferably, aforesaid coronary heart disease treatment medicament, be made of with the raw material of following weight proportions,
Optimally, aforesaid coronary heart disease treatment medicament, it is with the raw material system of following weight proportions Into,
In aforesaid coronary heart disease treatment medicament, the formulation of described medicament be powder, tablet, Oral liquid or capsule.
In the preparation method of aforesaid coronary heart disease treatment medicament, described powder is as follows Prepare:Each active compound is ground to form and mix in proportion after fine powder and cross 250-400 mesh sieves, as Powder.
In the preparation method of aforesaid coronary heart disease treatment medicament, described tablet is in the steps below Prepare:Each active compound is ground to form and mix in proportion after fine powder and cross 300-500 mesh sieves, sieved It is tabletted afterwards.
In the preparation method of aforesaid coronary heart disease treatment medicament, described oral liquid presses following steps It is rapid to prepare:Total raw material is pressed into medicine:The volume ratio of water is 1:2-4 soaks at least 1h, then Plus suitable quantity of water is decocted to consider after 1-3h and removes the dregs of a decoction.
In the preparation method of aforesaid coronary heart disease treatment medicament, described capsule is made in the steps below It is standby:Total raw material is pressed into medicine:The volume ratio of water is 1:2-10 soaks at least 2h, then adds appropriate Decocting boils 1-1.5h, filters off the dregs of a decoction, by the Chinese medicine leaching of clarification under conditions of negative pressure, low temperature Liquid is concentrated into Bomi degree for more than 75%, and by powder spraying apparatus dry powder is made, and the temperature of spout≤ 100 DEG C, then make capsule after addition filler in dry powder.
Radix Angelicae Sinensis, it is warm in nature, it is sweet, pungent.Return liver, the heart, the spleen channel.Replenishing and activating blood, menstruction regulating and pain relieving, Relax bowel.Radix Angelicae Sinensis can improve internal hypercoagulative state, adjust blood lipid metabolism, reduce cholesterol.
Cultivated land, sweet, tepor.Return liver and kidney channel.Enrich blood yin-nourishing, life essence-filling, marrow-benefitting.Prepared rhizome of rehmannia energy Significantly inhibit liver hemorrhagic necrosis and simple necrosis;The hyperlipemia that high lipid food is caused The vena hepatica haemorrhage that disease, fatty liver and rat endotoxin cause, there is inhibition thrombosis Effect;Activation to plasminogen, is antithrombotic mechanism of action.
Saline cistanche, return through is sweet, salty, temperature.Return kidney, large intestine channel.Kidney-replenishing, benefiting essence-blood, profit Intestines defaecation.《Bencao Jingshu》:The key medicine of nourshing kidney replenishing vital essence and blood, sweet energy heat extraction bowl spares, acid can enter Liver, salty energy nourshing kidney, kidney liver is the moon, and cloudy gas is grown, then the labor heat of the five internal organs is moved back certainly, penis syncope due to pathogenic cold Hot pain self-healing.
The dried rhizome of rehmannia, it is sweet, tremble with fear.The thoughts of returning home, liver and kidney channel.Clearing heat and cooling blood, yin-nourishing is promoted the production of body fluid.For The deep red polydipsia of pyreticosis tongue, yin asthenia generating intrinsic heat, hectic fever due to yin labor heat, Heat Diabetes is spitted blood, and maggot blood sends out spot Dermexanthesis.
Ginseng, mild-natured, sweet, slight bitter, tepor.Returns spleen, lung channel.Reinforce vital energy, multiple arteries and veins Gu it is de-, reinforce the spleen to benefit the lung, promote the production of body fluid to quench thirst, tranquilize the mind and promote the intelligence.Ginseng has protective effect to cardiac muscle.People Ginseng soap two can reduce the lactic acid content of mouse brain and cardiac muscle in the case of severe depletion of oxygen, can recover Content of cAMP/cGMP ratios during anoxic, and with protection heart muscle capillary endothelial cell and subtract The effect of light injury of mitochondria.
The tuber of dwarf lilyturf, sweet, slight bitter is slightly cold.The thoughts of returning home, lung, stomach.Nourishing Yin and promoting production of body fluid, moistening lung clears away heart-fire. For dryness of the lung dry cough.Empty carbuncle cough, injury thirst, vexed insomnia, Heat Diabetes, intestinal dryness is just It is secret;Pharyngeal diphtheria.The tuber of dwarf lilyturf increases may myocardial alimentary blood flow after infraction, the heart of hypoxic-ischemic Myocyte comparatively fast obtains reparation with protection, and the release for causing myocardium cGMP and cAMP is reduced, so as to The content in blood plasma is reduced, and makes both ratio restore balance.
The fruit of Chinese magnoliavine, temperature;It is sour, sweet;Return lung, the heart, kidney channel.Astringent or styptic treatment for spontaneous sweating, nourishing generate fluid is restrained, is mended Kidney calming heart.The fruit of Chinese magnoliavine has vasodilative effect.Schizandrin, schisandrin C, the deoxidation fruit of Chinese magnoliavine Elements etc. have inhibitory action in vitro dog mesenteric artery shrinks, and can increase arteries and veins mouse isolated heart And anesthesia dog CF.The fruit of Chinese magnoliavine is conducive to histiocytic oxygen exchange, can be to heart Tissue produces protective effect, also gently palmic rate and fibre can solve hypertension.
Radix Glycyrrhizae, mild-natured, sweet, return 12 warps.Have removing toxic substances, eliminating the phlegm, pain relieving, spasmolysis so that The pharmacological actions such as anticancer.Invigorate the spleen and benefit qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain reconciles All medicines.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, institute's abdomen, four limbs Contraction urgency pain, carbuncle sore tumefacting virus alleviate drug toxicity, strong.
The Radix Astragali, property is sweet, tepor.Return lung, spleen, liver and kidney channel.There are invigorating qi for consolidating superficies, arrest sweating solid The effect of de-, torr sore myogenic, inducing diuresis for removing edema.The Radix Astragali can strengthen myocardial contractive power, coronary artery dilating, Improve myocardial blood flow and myocardial metabolism, improve superoxide dismutase activity, lower lipid peroxy Compound content, so as to mitigate the damage that free radical is caused.
Radix scrophulariae is sweet, bitter, salty;Cold nature.Return lung, stomach, kidney channel.Warm heresy is joined the army, interior Sunken pericardium, febrile virulent maculae, the deep red polydipsia of consumption of YIN caused by febrile disease, tongue, Tianjin hinder constipation, hectic fever due to yin labor is coughed, mesh Red, pharyngalgia, cold carbuncle, diphtheria, carbuncle sore tumefacting virus.
The red sage root, it is bitter, it is slightly cold.The thoughts of returning home, Liver Channel.Promoting blood circulation for regulating menstruation, addiction of dispelling pain relieving, cool blood to disappear carbuncle, Relieving restlessness that clears away heart-fire, nourishing blood and tranquilization.The red sage root can promoting blood circulation addiction, remove obstruction in channels to relieve pain, blood-nourishing calming heart can increase Plus coronary heart disease CBF, improve myocardial contractive power, and do not increase myocardial anoxia amount, promote collateral Circulation and blood flow reallocation.
Fructus amomi, taste is pungent is warm in nature.Returns spleen Jing, stomach, kidney channel.《Medical center bun will》:Profit kidney, Tonifying liver, mends the gate of vitality, and taste, relieving stagnation.
Ligusticum wallichii, pungent, temperature.Return liver, courage, pericardium channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.For Pacify nerve, positive head wind headache, disease addiction stomachache, chest side of body shouting pain, tumbling and swelling, headache, wind Pain of dampness syndrome.Ligusticum wallichii can expand smooth muscle, improve microcirculation, and have anti-freezing, resistant to aggregation effect, And be depressured by expanding peripheral vessel.
Honeysuckle flower, it is sweet, cold.Attach to the lung and stomach meridians.Effect:It is clearing heat and detoxicating.With effect for reducing blood fat.
Compared with prior art, medicine of the present invention captures dihuang drink, Shengmai San, cassia twig Radix Glycyrrhizae The length of all sides such as soup, shenfu decoction, danggui buxue decoction, Danshen, Simiao Yongan Tang, Zengye Tang, And form with reference to Long-term clinical experience addition or subtraction of changes.The medicine of the present invention cultivated land help kidney of sweet temperature It is cloudy;Saline cistanche temperature invigorating kidney yang, with this work(of tonifying both YIN and YANG can be played;Shengmai San, with its ginseng sweet temperature Nourishing generate fluid is with tonifying lung, and the prosperous then all dirty gas of lung qi is all prosperous, the source of the tuber of dwarf lilyturf sweet cold yin-nourishing moisturizing, Fruit of Chinese magnoliavine acid temperature is astringed the lung and is promoted the production of body fluid, entirely can nourishing generate fluid, astringing YIN to stop sweating;Shenfu decoction invigorates vital energy and reinforce the heart Establishing-Yang, warm promoting blood circulation, often make heart infarction, the first aid side of heart failure;Cassia twig, Radix Glycyrrhizae are warming heart yang, Specially control the palpitaition of heart-yang void;Danggui buxue decoction, with the gas of Radix Astragali tonifying spleen lung, as a means of biochemistry, when Return nourishing blood and promoting blood circulation, play the work(of qi-supplementing, blood-engendering;Danshen in side, the red sage root is promoting blood circulation and removing blood stasis, pain relieving and Not impairment of QI-blood, santal, fructus amomi middle benefit gas promoting qi circulation and relieving pain, this taste of medicine three, mild in medicine property and, qi and blood simultaneously Control, both can stagnation resolvation promoting qi circulation and relieving pain, be again the cold disease retardance for the treatment of, the chest impediment and cardialgia of hypofunction of YANG QI in chest Good recipe, more promoting blood circulation and removing blood stasis with Ligusticum wallichii, mountain quarrel, analgesic effect is more preferably;Honeysuckle flower, radix scrophulariae agree without prior consultation works as Return, Radix Glycyrrhizae is Simiao Yongan Tang, can clearing heat and detoxicating, promoting blood circulation and stopping pain, then with the red sage root live painstaking effort, Nourishing heart scattered silt, treatment is pained more to see its work(.
It is simultaneous to suffer from glycosuria patient much during clinical diagnosis is for the patient of coronary heart disease, and diabetes are anti- Come over and make coronary heart disease to increase, while coronary heart disease is treated, it is necessary to pay attention to the control of diabetes, The Radix Astragali, the dried rhizome of rehmannia, radix scrophulariae, the red sage root in side, modern medicine study shows all there is drop blood well Sugar effect.Furthermore, patients with coronary heart disease is particularly senile patients with coronary heart disease and suffers from constipation person much, Because constipation makes difficult defecation, in straining at stool, the increase of cardiac pressure load, easily induction Heart infarction die suddenly, therefore, side in the dried rhizome of rehmannia, radix scrophulariae, the tuber of dwarf lilyturf constitute Zengye Tang, work(fluid dryness, Relax bowel.
With the effect of marking, answer positive evil removing is consolidated, it is to be to nurse one's health renal function to the present invention The key link for the treatment of, while focusing on the coordination of function of the internal organs such as kidney, the heart, liver, spleen, makes kidney Cloudy to grow, lower unit obtains that warm, qi and blood must be mended, extravasated blood must be solved, heat toxin can be clear, not only can lipid-loweringing Anti-freezing, reduction blood viscosity, thrombus can also improve function of vascular endothelium, release Vasopasm, anti arteriosclerosis, stable vulnerable plaque;Blood, vascular lesion are had dual Therapeutic action, can effectively treat disease of cardiovascular system.
Applicant carried out following experiments, the provable present invention is with effective effect;
Inventor has successively received thousands of clients, and wherein emr treatment archives are as follows:Patient 1118 people, the wherein people of the male sex 708 altogether, the people of women 410.Age in the 40-55 year people of person 170, The 56-65 year people of person 594, more than the 66 years old people of person 354.In 1118 clients, the most short person of the course of disease More than 100 days, most elder was up to 12 years.
Usage and consumption:Oral capsule, a 5-6 grain, every 2g, three times a day, one It is within individual month a course for the treatment of;
General one course for the treatment of subjective symptoms of patient is obviously improved, three to four courses for the treatment of of Most patients Reach healing or effective.Detailed observed and recorded during medication, clinical curative effect analysis are shown in Table 1, by This prescription overall clinical efficacy rate is understood in table 1 up to 96.14%, and this is not found during treating Medicament has obvious toxic and side effect.
The clinical efficacy of table 1 is counted
Illness Number of cases Recovery from illness It is effective Effectively It is invalid Always there is rate
The stagnation of the heart blood 295 79 171 35 10 95.83%
Cold solidifying heart arteries and veins 25 3 9 11 2 92%
The motive is weak 224 56 146 15 7 96%
Heart-kidney yang deficiency 287 91 175 14 7 96.89%
Heart kidney-yin deficiency 287 85 174 22 6 97.56%
Amount to 1118 314 675 97 32 96.14%
Specific embodiment
Embodiment 1.A kind of coronary heart disease treatment medicament, it is with the raw material system of following weight proportions Into,
Above-mentioned coronary heart disease treatment pharmaceutical formulation is powder, tablet, oral liquid or capsule.
The preparation method of above-mentioned powder is:Each active compound is ground to form and mix in proportion simultaneously after fine powder Cross 250-400 mesh sieves, as powder.
The usage and consumption of above-mentioned powder:Orally, a 10-15g, a day three times, one The moon is a course for the treatment of.
The preparation method of above-mentioned tablet is:Each active compound is ground to form and mix in proportion simultaneously after fine powder 300-500 mesh sieves are crossed, it is tabletted after sieving.
The usage of above-mentioned tablet and the same powder of consumption.
The preparation method of above-mentioned oral liquid is:Total raw material is pressed into medicine:The volume ratio of water is 1:2-4 soaks at least 1h, then adds worry after suitable quantity of water decoction 1-3h to remove the dregs of a decoction.
The usage and consumption of above-mentioned oral liquid:Orally, a 60-70mL, a day three times, The course for the treatment of of January one.
The preparation method of above-mentioned capsule is:Total raw material is pressed into medicine:The volume ratio of water is 1:2-10 Soak at least 2h, then add suitable quantity of water to decoct 1-1.5h, filter off the dregs of a decoction, in negative pressure, low It is more than 75% that the Chinese medicine leaching liquid of clarification is concentrated into into Bomi degree under conditions of temperature, by dusting Equipment makes dry powder, temperature≤100 DEG C of spout, then makes after addition filler in dry powder Capsule.
The usage and consumption of above-mentioned capsule:Orally, a 5-6 grain, every 2g, one day three It is secondary, it is within one month a course for the treatment of.

Claims (8)

1. a kind of coronary heart disease treatment medicament, it is characterised in that:It is with following weight proportions Raw material is made,
2. coronary heart disease treatment medicament as claimed in claim 1, it is characterised in that:It is with The raw material of following weight proportioning is made,
3. coronary heart disease treatment medicament as claimed in claim 2, it is characterised in that:It is with The raw material of following weight proportioning is made,
4. the coronary heart disease treatment medicament as described in any one of claim 1-3, its feature exists In:The formulation of described medicament is powder, tablet, oral liquid or capsule.
5. the preparation method of coronary heart disease treatment medicament as claimed in claim 4, its feature exists In:Described powder is prepared as follows:Each active compound is ground to form and mix in proportion after fine powder Merged 250-400 mesh sieves, as powder.
6. the preparation method of coronary heart disease treatment medicament as claimed in claim 4, its feature exists In:Described tablet is prepared according to the following steps:Each active compound is ground to form and mix in proportion after fine powder Merged 300-500 mesh sieves, it is tabletted after sieving.
7. the preparation method of coronary heart disease treatment medicament as claimed in claim 4, its feature exists In:Described oral liquid is prepared according to the following steps:Total raw material is pressed into medicine:The volume ratio of water is 1:2-4 soaks at least 1h, then adds worry after suitable quantity of water decoction 1-3h to remove the dregs of a decoction.
8. the preparation method of coronary heart disease treatment medicament as claimed in claim 4, its feature exists In:Described capsule is prepared according to the following steps:Total raw material is pressed into medicine:The volume ratio of water is 1:2-10 soaks at least 2h, then adds suitable quantity of water to decoct 1-1.5h, filters off the dregs of a decoction, It is more than 75% that the Chinese medicine leaching liquid of clarification is concentrated into into Bomi degree under conditions of negative pressure, low temperature, Dry powder, temperature≤100 DEG C of spout are made by powder spraying apparatus, then is added in dry powder and is filled out Fill after agent and make capsule.
CN201510683211.4A 2015-10-20 2015-10-20 Agent for treating coronary heart disease and preparation method of agent Pending CN106581552A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510683211.4A CN106581552A (en) 2015-10-20 2015-10-20 Agent for treating coronary heart disease and preparation method of agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510683211.4A CN106581552A (en) 2015-10-20 2015-10-20 Agent for treating coronary heart disease and preparation method of agent

Publications (1)

Publication Number Publication Date
CN106581552A true CN106581552A (en) 2017-04-26

Family

ID=58555266

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510683211.4A Pending CN106581552A (en) 2015-10-20 2015-10-20 Agent for treating coronary heart disease and preparation method of agent

Country Status (1)

Country Link
CN (1) CN106581552A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112933184A (en) * 2021-03-01 2021-06-11 湖南鹍廷科技开发有限责任公司 Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112933184A (en) * 2021-03-01 2021-06-11 湖南鹍廷科技开发有限责任公司 Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101537060B (en) Medicine for treating AIDS
CN104758852A (en) Traditional Chinese medicine composition for treating hypertension
CN103585478B (en) Chinese medicinal composition for treating hypertension
CN103919910B (en) A kind of medicine for the treatment of coronary heart disease
CN100512852C (en) Composite Chinese medicine took orally for treating coronary heart disease
CN103301337B (en) Traditional Chinese medicine for treating bovine puerperal fever
CN106581552A (en) Agent for treating coronary heart disease and preparation method of agent
CN103536690B (en) Traditional Chinese medicine oral liquid for reducing blood pressure
CN103721228B (en) A kind of Chinese medicine composition for the treatment of epistaxis and preparation method thereof
CN106606725A (en) Traditional Chinese medicine for treating heart disease, and preparation method of traditional Chinese medicine
CN102512645A (en) Traditional Chinese medicine composition for treating lumbago due to cold dampness
CN105126034A (en) Pharmaceutical preparation for treating coronary heart disease
CN104189714A (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN104257813B (en) A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof
CN106606726A (en) Medicine for treating coronary heart disease and preparation method thereof
CN103212026A (en) Traditional Chinese medicine for treating cholelithiasis as well as preparation method and taking method thereof
CN105943639A (en) Traditional Chinese medicine composition assisting in treating chronic subdural hematoma
CN106581551A (en) Traditional Chinese medicine with blood-fat-reducing and anticoagulation functions and preparation method thereof
CN106310137A (en) Traditional Chinese medicine composition for treating qi stagnation and blood stasis syndrome due to coronary disease and angina and preparation method thereof
CN103655935A (en) Traditional Chinese medicine composition for treating hepatitis B
CN104758638A (en) Traditional Chinese medicine composition for treating gallstone
CN103961603A (en) Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels
CN103356959A (en) Pharmaceutical composition for treating hyperplasia of mammary glands
CN104547781A (en) Traditional Chinese medicine agentia for treating arteriosclerosis and preparation of thereof
CN104906516A (en) Traditional Chinese medicinal composition for treating coronary heart disease and preparation method of traditional Chinese medicinal composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170426